2 Dividend Aristocrats to Buy for Passive Income That Could Outperform the MarketThe Motley Fool • 09/12/22
Pick Either Johnson & Johnson Stock Or This Healthcare Company – Both Are Likely To Offer Similar ReturnsForbes • 09/12/22
ROSEN, A RESPECTED AND LEADING FIRM, Encourages Abbott Laboratories Investors to Secure Counsel Before Important Deadline in Securities Class Action - ABTNewsfile Corp • 09/11/22
INVESTOR ACTION REMINDER: The Schall Law Firm Encourages Investors in Abbott Laboratories with Losses of $100,000 to Contact the FirmNewsfile Corp • 09/09/22
ABT INVESTOR NOTICE: ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Abbott Laboratories Investors to Secure Counsel Before Important Deadline in Securities Class Action - ABTNewsfile Corp • 09/09/22
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Abbott Laboratories (ABT) Investors with Significant Losses to Contact Firm's Attorneys, Infant Formula-Related Securities Fraud Class Action FiledPRNewsWire • 09/08/22
SHAREHOLDER ACTION NOTICE: The Schall Law Firm Encourages Investors in Abbott Laboratories with Losses of $100,000 to Contact the FirmNewsfile Corp • 09/08/22
Three-Year Data on World's Smallest Heart Device Show Benefits of Fixing Holes in Newborn Hearts Without SurgeryPRNewsWire • 09/08/22
ABBOTT LABORATORIES (ABT) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Announces that a Securities Class Action Lawsuit Has Been Filed Against Abbott Laboratories (ABT)Newsfile Corp • 09/08/22
SHAREHOLDER ACTION REMINDER: The Schall Law Firm Encourages Investors in Abbott Laboratories with Losses of $100,000 to Contact the FirmNewsfile Corp • 09/07/22
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Abbott Laboratories Investors With Losses to Secure Counsel Before Important Deadline in Securities Class Action – ABTBusiness Wire • 09/05/22
ROSEN, A LEADING LAW FIRM, Encourages Abbott Laboratories Investors to Secure Counsel Before Important Deadline in Securities Class Action - ABTPRNewsWire • 09/04/22
INVESTOR NOTICE: Abbott Laboratories Investors with Substantial Losses Have Opportunity to Lead the Abbott Laboratories Class Action Lawsuit - ABTPRNewsWire • 09/03/22
EQUITY ALERT: Rosen Law Firm Encourages Abbott Laboratories Investors to Secure Counsel Before Important Deadline in Securities Class Action - ABTNewsfile Corp • 09/03/22
ABBOTT LABORATORIES SHAREHOLDER ALERT by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Reminds Investors With Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Abbott Laboratories - ABTBusiness Wire • 09/03/22
ABBOTT ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Abbott Laboratories and Encourages Investors to Contact the FirmBusiness Wire • 09/02/22
EQUITY ALERT: Rosen Law Firm Encourages Abbott Laboratories Investors to Inquire About Class Action Investigation – ABTBusiness Wire • 09/01/22
INVESTOR DEADLINE: Abbott Laboratories Investors with Substantial Losses Have Opportunity to Lead the Abbott Laboratories Class Action Lawsuit - ABTNewsfile Corp • 09/01/22
INVESTOR ALERT: Abbott Laboratories Investors with Substantial Losses Have Opportunity to Lead the Abbott Laboratories Class Action Lawsuit - ABTBusiness Wire • 09/01/22
New Data Show Abbott's HeartMate 3™ Heart Pump Extends Life Beyond Five Years for Advanced Heart Failure PatientsPRNewsWire • 08/29/22
